Clinical Trial Update: Ultrasound and Proteomics for Guselkumab Response Assessment in Crohn's Disease (UPGRADE).

View source ↗

Summary

This entry announces an ongoing clinical trial using ultrasound and proteomics to assess responses to guselkumab in Crohn's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• TREMFYA (guselkumab)

Snippet

Sponsor: University of Calgary | Conditions: Crohn's Disease of Both Small and Large Intestine | Status: RECRUITING